Risks of cancer for MLH1 and MSH2 mutation carriers

被引：0

作者：

Dowty, James G. ^{[1
]}

Win, Aung K. ^{[1
]}

Buchanan, Daniel ^{[2
]}

Thibodeau, Stephen N. ^{[3
]}

Casey, Graham ^{[4
]}

Lindor, Noralane M. ^{[5
]}

Gallinger, Steve ^{[6
]}

Le Marchand, Loic ^{[7
]}

Haile, Robert ^{[4
]}

Newcomb, Polly ^{[8
]}

Hopper, John L. ^{[1
]}

Jenkins, Mark A. ^{[1
]}

机构：

[1] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Parkville, Vic 3052, Australia

[2] Queensland Inst Med Res, Familial Canc Lab, Brisbane, Qld 4006, Australia

[3] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA

[4] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA

[5] Mayo Clin, Dept Med Genet, Rochester, MN USA

[6] Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada

[7] Univ Hawaii, Canc Res Ctr, Honolulu, HI 96813 USA

[8] Fred Hutchinson Canc Res Ctr, Canc Prevent Program, Seattle, WA 98104 USA

来源：

GENETIC EPIDEMIOLOGY | 2009年 / 33卷 / 08期

关键词：

D O I：

暂无

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

202

引用

页码：811 / 811

页数：1

共 50 条

[1] Cancer Risks for MLH1 and MSH2 Mutation Carriers
Dowty, James G.
Win, Aung K.
Buchanan, Daniel D.
Lindor, Noralane M.
Macrae, Finlay A.
Clendenning, Mark
Antill, Yoland C.
Thibodeau, Stephen N.
Casey, Graham
Gallinger, Steve
Le Marchand, Loic
Newcomb, Polly A.
Haile, Robert W.
Young, Graeme P.
James, Paul A.
Giles, Graham G.
Gunawardena, Shanaka R.
Leggett, Barbara A.
Gattas, Michael
Boussioutas, Alex
Ahnen, Dennis J.
Baron, John A.
Parry, Susan
Goldblatt, Jack
Young, Joanne P.
Hopper, John L.
Jenkins, Mark A.
[J]. HUMAN MUTATION, 2013, 34 (03) : 490 - 497
[2] Substantial unexplained variation in cancer risks for MLH1 and MSH2 mutation carriers
JG Dowty
AK Win
D Buchanan
RJ Macinnis
N Lindor
SN Thibodeau
G Casey
S Gallinger
L LeMarchand
P Newcomb
R Haile
J Goldblatt
S Parry
FA Macrae
JL Hopper
MA Jenkins
[J]. Hereditary Cancer in Clinical Practice, 10 (Suppl 2)
[3] Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 mutation carriers exhibit weak positive MLH1 staining
Mangold, E
Pagenstecher, C
Friedl, W
Fischer, HP
Merkelbach-Bruse, S
Ohlendorf, M
Friedrichs, N
Aretz, S
Buettner, R
Propping, P
Mathiak, M
[J]. JOURNAL OF PATHOLOGY, 2005, 207 (04): : 385 - 395
[4] Cancer risk in 348 French MSH2 or MLH1 gene carriers
Parc, Y
Boisson, C
Thomas, G
Olschwang, S
[J]. JOURNAL OF MEDICAL GENETICS, 2003, 40 (03) : 208 - 213
[5] Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers
Olschwang, Sylviane
Yu, Kai
Lasset, Christine
Baert-Desurmont, Stephanie
Buisine, Marie-Pierre
Wang, Qing
Hutter, Pierre
Rouleau, Etienne
Caron, Olivier
Bourdon, Violaine
Thomas, Gilles
[J]. JOURNAL OF CANCER EPIDEMIOLOGY, 2009, 2009
[6] A comparison of models used to predict MLH1, MSH2 and MSH6 mutation carriers
Pouchet, C. J.
Wong, N.
Chong, G.
Sheehan, M. J.
Schneider, G.
Rosen-Sheidley, B.
Foulkes, W.
Tischkowitz, M.
[J]. ANNALS OF ONCOLOGY, 2009, 20 (04) : 681 - 688
[7] MSH2 and MLH1 testing
Grzegorz Kurzawski
Janina Suchy
Jan Lubiński
[J]. Hereditary Cancer in Clinical Practice, 6
[8] MSH2 and MLH1 testing
Kurzawski, Grzegorz
Suchy, Janina
Lubinski, Jan
[J]. HEREDITARY CANCER IN CLINICAL PRACTICE, 2008, 6 (02) : 83 - 83
[9] MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers:: A study of hereditary nonpolyposis colorectal cancer families
Vasen, HFA
Stormorken, A
Menko, FH
Nagengast, FM
Kleibeuker, JH
Griffioen, G
Taal, BG
Moller, P
Wijnen, JT
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (20) : 4074 - 4080
[10] Cumulative incidence of extracolonic and colorectal cancers in MLH1 and MSH2 mutation carriers of HNPCC
Lin, KM
Shashidharan, M
Ternent, CA
Thorson, AG
Blatchford, GJ
Christensen, MA
Lemon, S
Lynch, HT
[J]. GASTROENTEROLOGY, 1997, 112 (04) : A1454 - A1454

← 1 2 3 4 5 →